Alli Weight Loss Drug Launched By GSK - Orlistat
Alli a weight loss drug has been launched by GSK. It is the first clinically proven over-the-counter weight loss aid to be available in pharmacies across the UK and Europe.
Pharmacists note that it is a category “p” product and will be charged at around £50 monthly, and have been informed to restrict sales to suitable customers only.
GSK is running a multi-million pound investment in pharmacy training, consumer marketing and a behavioural support programme. this will include access to an online Alli weight-loss programme, provicing support and tools to help people follow a sensible diet and encourage sustainable weight loss.
Manfred Scheske, president GSK Consumer Healthcare Europe, said: “Alli offers adults a real opportunity for losing weight. Alli has been well received by millions of people in the US and we are very excited about the number of people it could help across Europe achieve their goal to lose weight.”
GSK received a non-prescription European licence for the drug in January, marking the first time the Commission has approved a non-prescription product for weight loss. Alli (orlistat 60mg) is a lower-dose version of Roche’s prescription drug Xenical, which has been available for more than 10 years.
Alli and Xeniccal contain the same active ingredient, which acts locally within the digestive system to prevent absorption of fat. It does this by allowing fat to quickly pass straight through the body, prompting some unpleasant side effects in people who take the drug but contain to over-eat.
The drug is indicated for use in adults with a Body Mass Index (BMI) of 28 or more on a reduced calorie, lower-fat diet.
It was launched in the US in June 2007 and it is now the seventh-largest OTC brand in the country.
Clinical trials data shows that Alli, when used in conjunction with a reduced calorie, lower-fat diet, can help people lose 50% more weight than by dieting alone.
Comments
One Response to “Alli Weight Loss Drug Launched By GSK - Orlistat”


I have been dispensing Orlistat for many years and know it is safe, effective and it works. It doesn’t get absorbed so it doesn’t interferes with your body organs or other medication. More importantly it doesn’t cause malnutrition like some diet pills that make you feel full up or appetite suppressants. Weight loss with Alli is also more sustained in the long term.
It only has diet related treatment effects if you eat too much fat so it is most effective when you are on a low fat weight programme and even more effective in terms of weight and waist loss when you exercise.
Great if you can lose weight easily and naturally, great if you have a fast metabolism but if you don’t fit the above, if you are disabled and so on then Alli is really good.
More over a small loss in weight can improve health, quality of life, reduce risks of various cancers, diabetes, cardiovascular incidents and so on. I have also seen patients become more salubrious by feeling much better, gaining confidence and having a more positive outlook.
Alli is not a myth - it works and is the only clinically proven weight loss pill. I am excited it is more widely available now - it may not reverse the obesity epidemic but it will make a huge difference to a individual’s life especially if our advice is followed. My patients say it has made a huge difference to their lives and I believe it because I can see it.
Sulatn SID Dajani